July / August #93 : Neg/Pos

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents

Publisher's Letter



Mailbox

Sex Ed’s Rubber Rubout

PREPing For Sex

On Me, Not Inn Me

Out Of Data

MTV Goes CDC

I Go Shout Plenty

Class Pictures

Obituary

Time Out

Bill Me Later

Neg/Pos

Natal Attraction

Milestones

Wall Of Controversy

Shades Of Gray

Give Me Fever

Bad Meds

Hot And Bothered

Pass The Scalpel—And The Bucks

Northern Exposure

Cell Low, Cell High

Pillow Talk

Neg (-) But (+) For Lipo

A New Gay Plague?

Hard Workin’ Beans

Viread, Once A Wonder Drug

It's His Party

Out Of Sight

The Truth About Cats And Dogs (& A Horse And A Bird)

Getting’ Hot In Here

The Big Bang Theory

Walk This Way



Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


email print

July / August 2003

Neg/Pos

NEG

Federal health officials warned Johns Hopkins and UCSF researchers that using terms such as men who sleep with men, sex workers, needle exchange and anal sex may endanger grant applications.

A doc in New Delhi, India, stalled surgery on an HIVer for more than five months, demanding $50,000 in special protective apparel for himself before he’d operate on a patient five hospitals had already turned away.

100,000 U.S. HIVers
aren’t getting their meds, the CDC estimates, because federal and state funding for AIDS Drug Assistance Programs (ADAP) has “not kept pace with need.”

POS

San Francisco’s STOP AIDS Project—and its locally approved, sexually explicit materials and workshops—were vindicated after a yearlong federal investigation found it “in compliance.”

India’s first matchmaker for lovelorn HIVers, Kottaram George, has founded a school in Mangalore exclusively for HIV positive pupils—who are routinely excluded from India’s public schools.

GlaxoSmithKline has axed AIDS drug prices by as much as half for HIVers in 63 of the world’s poorest countries, making good on a  commitment to provide the meds at no profit.




[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Poll
Have you ever been diagnosed with diabetes or pre-diabetes?
Yes
No

Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.